Veazey, Ronald S.
- Tulane University of Louisiana · Pathology (NIH department code)
- Tulane University of Louisiana (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #3,968
- Rising Star
- R01 Holder
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2006 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Pathology
NIH Funding · FY2023
Linked Award Amount
$1.9M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#3,968
By linked amount among FY2023 PIs
Earliest Year Loaded
2006
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Veazey, Ronald S. as a PI. Multi-PI records show the full award amount for context.
- 75N93020D00007-P00002-759302000003-1N01Contact PIEvaluation of the Immunogenicity and Efficacy of HIV-1 SOSIP Envelope Protein Vaccine Delivered with or without Recombinant Viral Vector Vaccines$1.1Maward amount
- 5R01AI155156-04R01Contact PIVaccination with invariant MHC-II-linked accessory antigens for protection from HIV infectionTulane University of Louisiana · Pathology (NIH department code)$834.7Kaward amount
Award organization
Organizations that administered FY2023 awards listing Veazey, Ronald S. as a PI.
FY2023 award administered by Tulane University of Louisiana (LA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2006First NIH AwardTulane University of Louisiana
- 2006$500K Cumulative Funding
- 2006$1M Cumulative Funding
- 2006Entered Top 50% NationallyRanked #4331
- 2006Entered Top 25% NationallyRanked #4331
- 2008$2M Cumulative Funding
- 2011R01 Grant Holder
- 2012$5M Cumulative Funding
- 2021$10M Cumulative Funding